| Financial Year |
March 31 2023 |
| Monetary Funds |
1,625,165,508.02 |
| Held-for-trading Financial Assets |
107,593,406.19 |
| Notes Receivable |
-- |
| Accounts Receivable |
468,671,882.82 |
| Advances to Suppliers |
415,522,643.31 |
| Other Receivables |
1,376,979,868.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
213,748,738.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
263,761,440.56 |
| Total Current Assets |
4,471,443,487.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
49,009,216.11 |
| Long-term Equity Investment |
2,034,804.64 |
| Investment Properties |
-- |
| Fixed Assetes |
12,110,649,573.08 |
| Under-construction Projects |
6,419,827,358.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
149,595,378.60 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,091,634,355.90 |
| Deferred Income Tax Assets |
1,724,425,981.03 |
| Other Non-Current Assets |
32,125,206.91 |
| Sub-Total of Non-Current Assets |
41,203,361,588.00 |
| Total Assets |
45,674,805,075.23 |
| Short-Term Loans |
12,055,161,577.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
78,913,503.39 |
| Accounts Payable |
1,125,472,925.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
501,835,466.07 |
| Taxes Payable |
166,955,497.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
364,092,563.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,936,722,187.09 |
| Other Current Liabilities |
26,766,546.34 |
| Sub-Total of Current Liabilities |
18,815,370,431.49 |
| Long-term Loans |
3,755,153,878.71 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,567,702,587.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
298,954,469.72 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
14,087,811.72 |
| Sub-Total of Non-Current Liabilities |
17,473,309,055.77 |
| Total Liabilities |
36,288,679,487.26 |
| Paid-In Capital(Or Share Stock) |
2,214,005,268.00 |
| Capital Surplus |
8,090,546,004.87 |
| Surplus Reserve |
709,394,584.02 |
| LESS:Treasury Stock |
52,002,164.55 |
| Undistributed Profits |
-499,073,507.90 |
| Minority Stockholder's Interest |
29,386,496.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,356,739,091.31 |
| Owner's Equity（Stockholder's Equity） |
9,386,125,587.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
45,674,805,075.23 |
